Victorian Infectious Diseases Reference Laboratory

Recent papers from Victorian Infectious Diseases Reference Laboratory

1. Bovine myxovirus resistance protein (Mx)1, but not Mx2, mediates antiviral activity against human and avian influenza A viruses, including H5N1 clade 2.3.4.4bJournal of Virology · 2026
2. No more excuses: viral hepatitis can be eliminatedThe Lancet · 2016
3. Multidimensional molecular profiling reveals decidual and circulating NK cell dynamics in early and late pregnancyEBioMedicine · 2026
4. Multiple outbreaks of norovirus caused by persistent transmission in a hospitality setting in Victoria, Australia, 2023Communicable Diseases Intelligence · 2026
5. Pathogen genome enrichment sequencing to support a city-wide Legionnaires’ disease outbreak investigationMicrobial Genomics · 2026
6. Antimicrobial resistance in Neisseria gonorrhoeae among men who have sex with men: a 10-year analysis with implications for doxycycline post-exposure prophylaxisJournal of Clinical Microbiology · 2026
7. Clinical utility of whole-genome sequencing in identifying a rare Mycobacterium species causing native joint infectionASM Case Reports · 2026
8. Intranasal xylometazoline hydrochloride to reduce intraoperative nasal hemorrhage in dogs undergoing ala‐vestibuloplasty for BOAS : A prospective, randomized studyVeterinary Surgery · 2026
9. Antiviral Resistance Associated With Multiple Mutations Occurring in Seasonal Influenza A( H3N2 ) Virus in a Patient Treated With OseltamivirClinical Case Reports · 2026
10. Reconciliation of titer differences between SARS-CoV-2 neutralizing antibody assaysJournal of Virology · 2026
11. Autodissemination stations suppress Aedes notoscriptus mosquitoes and reduce Buruli ulcer risk in urban Australia: a randomized controlled field trialNature Microbiology · 2026
12. COVID-19 disruption and rebound of respiratory syncytial virus hospital burden in Australia: A national interrupted time-series analysisJournal of Infection and Public Health · 2026
13. Metabolic reprogramming enables transient survival and envelope remodelling in Staphylococcus aureus under dalbavancin treatmentnpj Antimicrobials and Resistance · 2026
14. National genomic survey of drug-resistance and multi-jurisdictional clusters of Mycobacterium tuberculosis in Australia 2015–2023The Lancet Regional Health - Western Pacific · 2026
15. Enhanced surveillance for hepatitis B and C: insights into clinical care after diagnosisCommunicable Diseases Intelligence · 2026
16. Harmonization of measurement units: mission impossible or ethical imperative?Clinical Chemistry and Laboratory Medicine (CCLM) · 2026
17. An outbreak of Salmonella Waycross related to sandpit contamination in a Gold Coast childcare centre, Queensland, Australia, 2024Communicable Diseases Intelligence · 2026
18. Insights into epidemiological and clinical burden of bronchiolitis among hospitalized children: a call for preventive interventionsFrontiers in Pediatrics · 2026
19. Room-return ventilation and N95 respirator policies for reducing airborne pathogen exposure on hospital wardsJournal of Hospital Infection · 2026
20. Comparing Phenotypic Susceptibility Profiles of Neisseria gonorrhoeae for Tetracycline and DoxycyclineSexually Transmitted Diseases · 2026